Navigation Links
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007

d Audited

Revenues 16,248,209 16,705,845 5,807,214 5,452,608 21,734,553

Cost of sales,

refining and

services 14,999,682 15,748,614 5,468,311 5,320,488 20,584,260

_________ _________ _________ _________ _________

Gross profit 1,248,527 957,231 338,903 132,120 1,150,293

Selling expenses 96,965 70,245 37,020 23,624 94,634

General and

administrative

expenses 215,121 167,253 64,789 52,614 222,104

_________ _________ _________ _________ _________

Operating income 936,441 719,733 237,094 55,882 833,555

Financing (income)

expenses, net 80,309 91,814 (3,266) 23,333 106,589

_________ _________ _________ _________ _________

856,132 627,919 240,360 32,549 726,966

Privatization

Grant (118,529) - - - -

_________ _________ _________ _________ _________

Income before

taxes on income 737,603 627,919 240,360 32,549 726,966

Taxes on income 204,202 180,564 64,220 8,491 221,539

_________ _________ _________ _________ _________

533,401 447,355 176,140 24,058 505,427

Company's share

in income (losses)

of affiliated

companies 22,165 21,501 2,002 (129) 32,570

_________ _________ _________ _________ _________

Net income for the

period 555,566 468,856 1 78,142 23,929 537,997

_________ _________ _________ _________ _________

_________ _________ _________ _________ ____
'/>"/>

SOURCE Oil Refineries Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... NEW YORK , Oct. 20, 2014 /PRNewswire/ ... of their experimental ZMapp™ antibody therapeutic to fight ... of how difficult and time-consuming the production of ... healthcare market research publisher said that while some ... cycle of this compound, those with industry knowledge ...
(Date:10/20/2014)... MENLO PARK, Calif. , Oct. 20, 2014 ... announced today that the Company has signed a ... Institute of Regenerative Medicine (CIRM), effective October 1, ... of Clinical Development payments and the release of ... $14.3 million CIRM grant award for clinical development ...
(Date:10/20/2014)... VIENNA , October 20, 2014 ... of gastrointestinal (GI) disorders and the delivery of care ... liver diseases and worrying inequalities in the provision of ... survey, which was commissioned by United European Gastroenterology (UEG), ... greater political and public awareness of the burden of ...
(Date:10/20/2014)... Oct. 20, 2014 PureTech , a ... big healthcare problems, announced today the closing of ... participation from Invesco Perpetual, a $120 Billion group ... drive PureTech,s existing pipeline forward and to advance ... the scientific creativity to really go for the ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
... David Meyer to our team as the Vice President of ... the executive leadership in building upon the HumanTouch health strategy. ... (IT) experience and expertise HumanTouch has been cultivating for 15 ... more than 20 years of diverse experience in the health ...
... 2011 PharmAthene, Inc. (NYSE Amex: PIP ... the Russell Global Index and the Russell 3000 Index ... and global equity indexes on June 24, 2011.  The ... largest U.S. companies based on total market capitalization.  The ...
... 27, 2011 Chimerix, Inc., a pharmaceutical ... with the Biomedical Advanced Research and Development Authority (BARDA) ... Services (HHS) that will resolve the Government Accountability Office ... to SIGA Technologies, Inc. for the development and delivery ...
Cached Biology Technology:HumanTouch Welcomes David Meyer as Vice President of HumanTouch's new Health Solutions Division 2PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index 2PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index 3PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index 4Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract 2Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract 3Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract 4
(Date:10/18/2014)... genetic conditions, a certain type of exome sequencing method ... traditional molecular diagnostic methods, according to a study appearing ... to coincide with the American Society of Human Genetics ... region of the genome (the complete set of genes ... has been rapidly applied in research settings and recent ...
(Date:10/17/2014)... German . ... When treating overdoses, doctors are often limited to supportive therapy ... is a combination of drugs involved. So what can be ... grandmother,s pills? ETH professor Jean-Christophe Leroux from the Institute of ... to this question. "The task was to develop an agent ...
(Date:10/16/2014)... the bowel lining develops and, in the process, suggested ... The researchers produced evidence that stem cells are responsible ... feature of the bowel lining, and believe these stem ... finding as scientists are still divided on the stem ... Wee Tan and Professor Tony Burgess from the Walter ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3Cryptic clues drive new theory of bowel cancer development 2
... (Garrison NY) A Hastings Center workshop examining moral issues ... J. Craig Venter Group announced that it had created ... biology certainly raises deep philosophical and moral questions about ... a Hastings Center scholar who is managing the project. ...
... polluting some of California,s most popular beaches. Yet few ... systems and coastal contamination. Now, in ... have tracked a plume of polluted groundwater from a ... beaches. The researchers say their findings could be an ...
... ancient frogs may soon be mined to extinction, if the ... for mining go ahead. The primitive Archey,s frog ( ... are two of the species that inhabit the area of ... mining is planned to take place. Archey,s frog is ...
Cached Biology News:Stanford scientists track polluted groundwater to the sea 2Stanford scientists track polluted groundwater to the sea 3Stanford scientists track polluted groundwater to the sea 4Prehistoric frogs face extinction 2
... (GST) is commonly used as a fusion ... (1). The GSTTag sequence has been reported ... cases the solubility of its fusion partners. ... form, GSTTag fusion proteins can be purified ...
... The Bio-Stack is compatible with BioTeks ... Speed, ease of use and walkaway ... microplate process. When used with the ... dispenser, the Bio-Stacks small footprint fits ...
... for the use of small interfering RNA ... the RNA interference,(RNAi) pathway have generated tremendous ... fields. siRNA for experimental use can be,synthesized ... then transfected into the target cells in ...
... scientists who have access to microarray scanning and ... with proteins from S&Ss antibody menu or from ... performed by the customer. Its as easy as ... with an expert and define the best adapted ...
Biology Products: